Aprea Therapeutics Inc (APRE)
5.37
+0.25
(+4.88%)
USD |
NASDAQ |
Apr 23, 16:00
5.37
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics 1 Year Total Returns (Daily): 36.99% for April 23, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 23, 2024 | 36.99% |
April 22, 2024 | 30.62% |
April 19, 2024 | 31.77% |
April 18, 2024 | 31.69% |
April 17, 2024 | 41.48% |
April 16, 2024 | 42.68% |
April 15, 2024 | 43.90% |
April 12, 2024 | 40.99% |
April 11, 2024 | 41.15% |
April 10, 2024 | 47.27% |
April 09, 2024 | 36.64% |
April 08, 2024 | 40.27% |
April 05, 2024 | 64.06% |
April 04, 2024 | 55.03% |
April 03, 2024 | 59.19% |
April 02, 2024 | 48.65% |
April 01, 2024 | 43.02% |
March 28, 2024 | 45.12% |
March 27, 2024 | 29.15% |
March 26, 2024 | 28.70% |
March 25, 2024 | 32.25% |
March 22, 2024 | 26.97% |
March 21, 2024 | 26.24% |
March 20, 2024 | 26.47% |
March 19, 2024 | 30.37% |
Date | Value |
---|---|
March 18, 2024 | 26.69% |
March 15, 2024 | 18.58% |
March 14, 2024 | 2.51% |
March 13, 2024 | 8.72% |
March 12, 2024 | 22.22% |
March 11, 2024 | 34.33% |
March 08, 2024 | 44.74% |
March 07, 2024 | 53.29% |
March 06, 2024 | 61.60% |
March 05, 2024 | 55.62% |
March 04, 2024 | 60.00% |
March 01, 2024 | 53.85% |
February 29, 2024 | 64.91% |
February 28, 2024 | 40.35% |
February 27, 2024 | 43.68% |
February 26, 2024 | 40.20% |
February 23, 2024 | 43.37% |
February 22, 2024 | 1.01% |
February 21, 2024 | -0.32% |
February 20, 2024 | -9.25% |
February 16, 2024 | -17.92% |
February 15, 2024 | -26.94% |
February 14, 2024 | -27.20% |
February 13, 2024 | -37.66% |
February 12, 2024 | -32.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.83%
Minimum
Nov 21 2022
64.91%
Maximum
Feb 29 2024
-66.29%
Average
-79.80%
Median
Aug 11 2023
1 Year Total Returns (Daily) Benchmarks
NeuBase Therapeutics Inc | -86.21% |
Stoke Therapeutics Inc | 29.72% |
Processa Pharmaceuticals Inc | -84.73% |
NovaBay Pharmaceuticals Inc | -95.06% |
Palatin Technologies Inc | -31.91% |